MedGenome
About MedGenome
MedGenome is a leading genomics-based diagnostics and research company that focuses on providing advanced genetic testing services and solutions. The company aims to improve healthcare outcomes through the integration of genomics into clinical practice.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series E | Jul 21, 2025 | $47.5M | Maj Invest, Novo Holdings, MajInvest |
Founders
No founder information available.
Investors
Recent Mentions
We are pleased to share that Argus Partners advised @MedGenomeLabs Inc.(“MedGenome”), a leading, genomic diagnostics and research services company, on its Series E fundraise of approximately USD 47.5 million. The round was co-led by @MajInvest , along-with existing investor Novo https://t.co/oJbvsBblej
#Bangalore | MedGenome, announced that it has raised $47.5million in its Series E funding round, co-led by Maj Invest, a private equity firm joining as a new investor, along with existing investor Novo Holdings. https://t.co/LxypFeepZx
Similar Startups
CureGene Pharma
88% matchCureGene focuses on therapeutic areas including cardiovascular and metabolic diseases, developing in...
BillionToOneInc
87% matchA biotech company focused on diagnostics, specializing in innovative solutions for genetic testing a...
BiomEdit
87% matchAn animal health biotechnology company focused on developing innovative solutions for animal health ...
MedIQCME
86% matchA health tech platform focused on enhancing medical education and continuing medical education (CME)...